<img height="1" width="1" style="display:none" src="https://www.facebook.com/tr?id=319805651697215&amp;ev=PageView&amp;noscript=1">

ZenBio Engages Cryoport to Support Distribution of its Human Cell-Based Products

July 14, 2015

Read More


Tags: Global Cold Chain Logistics, Human Platelet Lysate, ZenBio, regenerative therapies

Cryoport Selected by Lynden International as the Preferred Cryogenic Logistics Provider

June 10, 2015

Lake Forest, CA, June 10, 2015 - Cryoport, Inc. (OTCBB: CYRX) (“Company”), the leading provider of advanced cryogenic logistics solutions for the life sciences industry, serving markets including immunotherapies, stem cells, cell lines, clinical research organizations, vaccine manufacturers, animal health, and reproductive medicine, today announced that it has been selected by Lynden International (“Lynden”) as its preferred provider to support cold chain clinical trial logistics for underrepresented diseases in Africa.

Read More


Tags: Clinical Trials Logistics, cryogenic frozen, Global Cold Chain Logistics, Lynden

Cryoport to Support the Equine Animal Husbandry Market Through Agreement with Yancey Farms

April 23, 2015

Lake Forest, CA, April 23, 2015 - Cryoport, Inc. (OTCBB: CYRX) (“Company”), the leading provider of advanced cryogenic logistics solutions for the life sciences industry, today announced that the Company has further established its cryogenic logistics solutions within the animal husbandry market by signing a new customer agreement with Yancey Farms to support the shipment of equine semen for artificial insemination of top German Sport horse Stallions.

Read More


Tags: Global Cold Chain Logistics, Animal Husbandry, Yancey Farms